Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM45A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TOMM70 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NIT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TFG - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ABI3BP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FILIP1L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IMPG2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COL8A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC100287852 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SENP7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PCNP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZBTB11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPL24 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DCBLD2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ST3GAL6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on